According to AlphaMoat, in October 2026 Evozyne (evozyne.com) received 442 monthly visits (-85.8% MoM) — ranked #17,018 of 17,609 AI websites with traffic data, and #986 of 1,014 in Education & Research; its largest market is United States (100.0% of visits).
Evozyne uses generative artificial intelligence to design novel therapeutic proteins for patient needs in immune-mediated diseases unmet by existing biologics and small molecules, positioning itself as an AI-native protein-design company.
| Month | Monthly visits | MoM |
|---|---|---|
| 2026-06 | 5.0K | — |
| 2026-07 | 2.7K | -45.9% |
| 2026-08 | 2.8K | +5.3% |
| 2026-09 | 3.1K | +10.2% |
| 2026-10 | 442 | -85.8% |
An AI teaching platform that helps educators create activities and track learning progress.
+ CompareAn integrated text toolkit combining AI-content detection with writing assistance.
+ CompareA content-authenticity tool for detecting AI text, writing history, and questionable citations
+ CompareBring academic editing, citation formatting, and similarity checks together
+ CompareAccording to AlphaMoat, Evozyne (evozyne.com) received 442 visits (about 442) in October 2026 (-85.8% month over month), ranking #17,018 of 17,609 AI websites with traffic data, and #986 in Education & Research.
In Education & Research, the other products with the most monthly visits are Wayground AI (47.1M), ZeroGPT (32.9M), GPTZero (23.2M), Gizmo (9.3M), Scribbr (7.5M).
Data month: 2026-10 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.